GENEREX BIOTECHNOLOGY CORP company info

CIK 1059784
IRS Number 820490211
State of incorporation DE
Business address 10102 USA TODAY WAY
None
MIRAMAR
FL
33025
Mail address 10102 USA TODAY WAY
None
MIRAMAR
FL
33025

Short summary

GENEREX BIOTECHNOLOGY CORP is a Florida company, with head office located at 10102 Usa Today Way Miramar, Florida 33025. The company achieved a record breaking net income last year - 35.95 million USD. This is -146.79% higher than one reported in 2017. In 2018 the company owned a total of 21.35 million USD worth of assets, including 6.38 million USD worth of current assets. 2010 was the year when the company amassed the most assets.

GENEREX BIOTECHNOLOGY CORP Income Statement

Name [in Millions USD]199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018Trends
Gross Profit 0.590.360.140.02
Research and development 13.5613.3610.254.992.191.381.190.470.420.84
Operating Expenses 26.8529.7924.6710.046.134.403.881.901.603.20
Operating Income (Loss) -26.26-29.43-24.53-10.02-6.13-4.40-3.88-1.90-1.60-2.50
Interest expense 20.110.210.210.590.530.320.350.420.740.58
Other Nonoperating Income (Expense) 0.000.000.490
Net income -1.38-4.66-6.24-8.84-27.10-13.69-13.26-18.36-24.00-67.97-23.50-36.23-45.81-25.28-21.68-9.49-8.55-0.00-2.19-3.22-76.8335.95

GENEREX BIOTECHNOLOGY CORP Balance Sheet

Name [in Millions USD]199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 017.2414.202.801.190.414.220.930.050.041.572.36
Accounts Receivable, Net, Current 0.0700
Inventories 1.91000.020.010.84
Property, Plant and Equipment, Gross 6.711.570.510.010.010.01
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 5.440.860.420.010.010.010.120.15
Goodwill 14.308.88
Intangible Assets, Net (Excluding Goodwill) 1.963.193.19
Total assets 24.586.273.625.522.811.2913.197.7621.35
Current assets 16.201.490.484.260.970.064.071.746.38
Total current liabilities 8.108.758.288.267.858.7323.9925.0542.95
Long-term Debt, Excluding Current Maturities 1.820.570
Long-term Debt 3.081.660.62
Total liabilities 15.6013.9211.7214.8510.5410.1780.6566.2846.95
Common Stock, Value, Issued 0.270.350.500.780.810.900.000.000.03
Retained Earnings (Accumulated Deficit) 372372-373.34437424392
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.780.770.760.770.790.790.810.790.80

GENEREX BIOTECHNOLOGY CORP Cash Flow

Name [in Millions USD]199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018Trends
Net income -1.38-4.66-6.24-8.84-27.10-13.69-13.26-18.36-24.00-67.97-23.50-36.23-45.81-25.28-21.68-9.49-8.55-0.00-2.19-3.22-76.8335.95
Depreciation and amortization 0.140.070.030.030
Depreciation 0.240.170.100.040.010.000.000.000.02
Amortization of Intangible Assets 0000.440.320.000.000.00
Depreciation and amortization 0.810.780.740.610.460.370.380.270.010.02
Accounts receivable -0.010.01-0.06-0.010.00-0.03
Inventories -0.150.62-1.20-0.720.01-0.00
Deferred revenue 0.010.25-0.03-0.11-0.04-0.00-0.22
Net Cash Provided by (Used in) Operating Activities -22.65-22.31-16.93-8.04-3.66-3.57-2.88-0.78-1.17-2.29
Payments to Acquire Property, Plant, and Equipment 0.000.160.050.00
Payments to Acquire Intangible Assets 0.150.230.230.170.080.090.09
Net Cash Provided by (Used in) Investing Activities 8.70-0.39-0.294.781.690.79-0.090.01-0.01
Proceeds from Issuance of Long-term Debt 0003.560.830.05
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.100.070.020.010.001.551.401.000.100.100.100.130.130.130.12
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.100.070.020.010.001.551.401.000.100.100.100.130.130.130.12
Proceeds from Issuance of Common Stock 15.4520.903.940
Payments for Repurchase of Common Stock 0000
Net Cash Provided by (Used in) Financing Activities 10.9922.336.130.753.464.350.480.054.040.45
Cash and Cash Equivalents, Period Increase (Decrease) -3.04-0.32-11.08-2.551.461.56-2.52-0.732.86-1.83